TASS [Russian State News]: Boehringer Ingelheim and Vanderbilt University Expand Partnership

INTELROBOTS's picture

Boehringer Ingelheim and Vanderbilt University collaborate to develop novel anti-cancer drugs that inhibit the MCL1 (myeloid cell leukemia 1) protein

MAGAZINE ADVERTISEMENT

MAGAZINE ADVERTISEMENT